Salt Lake Potash Ltd‘s (ASX:SO4) pilot plant test work on salts from the Lake Way project has confirmed a highly water-soluble premium sulphate of potash (SOP) product with a potassium oxide grade exceeding 53%.
Keywords Studios PLC (LON:KWS) has expanded its global empire with the acquisition of German dubbing specialist TV+SYNCHRON Berlin (TVS). In a separate announcement, Keywords reported that for the six months ended 30 June an adjusted pre-tax profit of €18.4mln, up 14.3% on the prior year, while the interim dividend was hiked to 0.58p per share from 0.53p.
Nektan PLC (AIM: NKTN) is proposing a capital restructuring to strengthen its balance sheet as its business-to-business arm begins integrating new clients at a rapid rate across Asia and Africa.
Landore Resources Limited (LON:LND) has raised £470,000 through a share subscription to fund exploration of its BAM Gold deposit in Ontario, Canada.
Oncimmune Holdings PLC (LON:ONC) will deliver a keynote presentation at the China BioMed Innovation and Investment Conference this Sunday in Suzhou, China, with chief executive Adam Hill giving an overview of the company and progress in delivering its strategy.
Summit Therapeutics PLC (LON:SUMM) (NASDAQ:SMMT) has flagged up an editorial in the Future Microbiology journal calling for the development of antimicrobial products to combat resistance to antibiotics. Summit is developing Ridinilazol, a new class antibiotic for the treatment of C. difficile infection, where current treatments fail in about a third of cases. Dr David Roblin, president of research and development at Summit, said: “Our approach to antibiotic drug development aims to end the perception that new antibiotics are ‘break-in-emergency’ treatments.”
Ticketing software specialist accesso Technology Group PLC (LON: ACSO) says it expects the cost of its new unified product strategy will be lower than expected.